BioStock has published an interview with CEO Sten R. Sörensen on the minimum 250 MSEK loan financing
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for diseases with high unmet medical needs, today announced that BioStock has published an executive interview on the Company securing minimum 250 MSEK loan financing to reach set milestones into 2026.In the interview, Cereno’s CEO Sten R. Sörensen comments on the financing agreement to reach set milestones into 2026, and how this will influence the business and the shareholders. View the video here